Visceral leishmaniasis in District Dir, NWFP.
Visceral leishmaniasis is endemic in District Dir, NWFP. We evaluated 10 patients with visceral leishmaniasis at DHQ Hospital Timergara District Dir, N.W.F.P. All patients were in the age range 2 to 10 years. The predominant clinical features in these were chronic fever (10), splenomegaly (10), hepatomegaly (10), weight loss (10) and abdominal distention (5). Lymphadenopathy was absent. Common laboratory abnormalities included anaemia (10), leucopenia (7), thrombocytopenia (10) and hypergammaglobulinaemia (10). Formal Gel test was positive in all patients (100%) and all had positive bone marrow smears for Leishmania Donovani (L.D.) bodies (10). The response to stibogluconate (Glucantime Sodium) therapy was good with a 100 percent cure rate.
Rahim
F
F
DHQ Hospital, Timergara, N.W.F.P.
Rehman
F
F
Ahmad
S
S
Zada
B
B
D000005:Abdomen / Q000473:pathology; D000740:Anemia / Q000503:physiopathology; D000818:Animals; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000469:parasitology; D002648:Child; D002675:Child, Preschool; D005260:Female; D005334:Fever / Q000503:physiopathology; D006529:Hepatomegaly / Q000503:physiopathology; D006801:Humans; D006942:Hypergammaglobulinemia / Q000503:physiopathology; D007893:Leishmania donovani / Q000302:isolation & purification; D007898:Leishmaniasis, Visceral / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D007970:Leukopenia / Q000503:physiopathology; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D010154:Pakistan; D013163:Splenomegaly / Q000503:physiopathology; D013921:Thrombocytopenia / Q000503:physiopathology; D015431:Weight Loss / Q000502:physiology
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony